HUP0500617A3 - Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders - Google Patents
Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disordersInfo
- Publication number
- HUP0500617A3 HUP0500617A3 HU0500617A HUP0500617A HUP0500617A3 HU P0500617 A3 HUP0500617 A3 HU P0500617A3 HU 0500617 A HU0500617 A HU 0500617A HU P0500617 A HUP0500617 A HU P0500617A HU P0500617 A3 HUP0500617 A3 HU P0500617A3
- Authority
- HU
- Hungary
- Prior art keywords
- disorders
- identification
- treatment
- methods
- cell proliferation
- Prior art date
Links
- 230000001594 aberrant effect Effects 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000004663 cell proliferation Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31750401P | 2001-09-05 | 2001-09-05 | |
| PCT/US2002/028176 WO2003020909A2 (en) | 2001-09-05 | 2002-09-04 | Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0500617A2 HUP0500617A2 (hu) | 2005-10-28 |
| HUP0500617A3 true HUP0500617A3 (en) | 2012-05-02 |
Family
ID=23233944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0500617A HUP0500617A3 (en) | 2001-09-05 | 2002-09-04 | Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1432446B1 (hu) |
| JP (2) | JP5224632B2 (hu) |
| KR (3) | KR20100061863A (hu) |
| CN (2) | CN101446590A (hu) |
| AT (1) | ATE506965T1 (hu) |
| AU (1) | AU2002332838B2 (hu) |
| BR (1) | BR0212641A (hu) |
| CA (1) | CA2457541C (hu) |
| DE (1) | DE60239881D1 (hu) |
| DK (1) | DK1432446T3 (hu) |
| HU (1) | HUP0500617A3 (hu) |
| IL (2) | IL160659A0 (hu) |
| MX (1) | MXPA04002084A (hu) |
| NZ (1) | NZ531515A (hu) |
| PL (1) | PL374363A1 (hu) |
| WO (1) | WO2003020909A2 (hu) |
| ZA (1) | ZA200401751B (hu) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8088387B2 (en) * | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| US7276497B2 (en) | 2003-05-20 | 2007-10-02 | Immunogen Inc. | Cytotoxic agents comprising new maytansinoids |
| BRPI0410748B8 (pt) * | 2003-05-20 | 2021-05-25 | Immunogen Inc | compostos de maitansinóides, suas composições farmacêuticas, métodos de esterificação de maitansinóides, bem como métodos para a sua produção, e conjugado de maitansinóide-agente de ligação celular |
| CN101087611B (zh) * | 2003-10-10 | 2019-04-23 | 伊缪诺金公司 | 用经不可切割接头连接的细胞结合剂美登木素生物碱偶联物靶向特定细胞群的方法、所述偶联物和制备所述偶联物的方法 |
| EP2247304B1 (en) * | 2008-04-02 | 2016-05-25 | MacroGenics, Inc. | Her2/neu-specific antibodies and methods of using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2026147C (en) * | 1989-10-25 | 2006-02-07 | Ravi J. Chari | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| DE60020529T2 (de) * | 1999-03-01 | 2006-04-27 | Genentech Inc., San Francisco | Antikörper zur krebsbehandlung und -diagnose |
| EP1226177B1 (en) * | 1999-10-29 | 2008-07-09 | Genentech, Inc. | Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| WO2001055720A2 (en) * | 2000-01-26 | 2001-08-02 | Ventana Medical Systems, Inc. | A system for developing assays for personalized medicine |
-
2002
- 2002-09-04 DK DK02797854.3T patent/DK1432446T3/da active
- 2002-09-04 WO PCT/US2002/028176 patent/WO2003020909A2/en active Application Filing
- 2002-09-04 EP EP02797854A patent/EP1432446B1/en not_active Expired - Lifetime
- 2002-09-04 IL IL16065902A patent/IL160659A0/xx unknown
- 2002-09-04 JP JP2003525613A patent/JP5224632B2/ja not_active Expired - Fee Related
- 2002-09-04 AU AU2002332838A patent/AU2002332838B2/en not_active Ceased
- 2002-09-04 PL PL02374363A patent/PL374363A1/xx not_active IP Right Cessation
- 2002-09-04 NZ NZ531515A patent/NZ531515A/en not_active IP Right Cessation
- 2002-09-04 KR KR1020107011044A patent/KR20100061863A/ko not_active Application Discontinuation
- 2002-09-04 HU HU0500617A patent/HUP0500617A3/hu unknown
- 2002-09-04 MX MXPA04002084A patent/MXPA04002084A/es active IP Right Grant
- 2002-09-04 KR KR10-2004-7003327A patent/KR20040044850A/ko not_active Application Discontinuation
- 2002-09-04 AT AT02797854T patent/ATE506965T1/de not_active IP Right Cessation
- 2002-09-04 KR KR1020097019746A patent/KR20090104925A/ko not_active Application Discontinuation
- 2002-09-04 BR BR0212641-9A patent/BR0212641A/pt active Pending
- 2002-09-04 DE DE60239881T patent/DE60239881D1/de not_active Expired - Lifetime
- 2002-09-04 CN CNA2008101656506A patent/CN101446590A/zh active Pending
- 2002-09-04 CN CNA02821529XA patent/CN1578673A/zh active Pending
- 2002-09-04 CA CA2457541A patent/CA2457541C/en not_active Expired - Fee Related
-
2004
- 2004-03-01 IL IL160659A patent/IL160659A/en not_active IP Right Cessation
- 2004-03-03 ZA ZA2004/01751A patent/ZA200401751B/en unknown
-
2010
- 2010-08-04 JP JP2010175090A patent/JP2010280691A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1432446B1 (en) | 2011-04-27 |
| IL160659A0 (en) | 2004-08-31 |
| AU2002332838B2 (en) | 2007-08-02 |
| ZA200401751B (en) | 2005-07-27 |
| CN101446590A (zh) | 2009-06-03 |
| BR0212641A (pt) | 2005-04-12 |
| EP1432446A4 (en) | 2004-09-08 |
| EP1432446A2 (en) | 2004-06-30 |
| ATE506965T1 (de) | 2011-05-15 |
| CA2457541A1 (en) | 2003-03-13 |
| DK1432446T3 (da) | 2011-07-18 |
| PL374363A1 (en) | 2005-10-17 |
| HUP0500617A2 (hu) | 2005-10-28 |
| MXPA04002084A (es) | 2004-06-07 |
| WO2003020909A3 (en) | 2003-11-20 |
| JP5224632B2 (ja) | 2013-07-03 |
| JP2010280691A (ja) | 2010-12-16 |
| JP2005517155A (ja) | 2005-06-09 |
| CN1578673A (zh) | 2005-02-09 |
| KR20040044850A (ko) | 2004-05-31 |
| KR20090104925A (ko) | 2009-10-06 |
| DE60239881D1 (de) | 2011-06-09 |
| NZ531515A (en) | 2007-11-30 |
| KR20100061863A (ko) | 2010-06-09 |
| WO2003020909A2 (en) | 2003-03-13 |
| IL160659A (en) | 2011-07-31 |
| CA2457541C (en) | 2013-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002339691A1 (en) | Agonists and antagonists of prolixin for the treatment of metabolic disorders | |
| MXPA03007960A (es) | Compuestos y metodos para el tratamiento de desordenes urogenitales. | |
| AU2002361602A1 (en) | Identity card and system for tracking the use of the card | |
| IL160550A0 (en) | Plaster for the treatment of dysfunctions and disorders of nail growth | |
| EP1448669A4 (en) | POLYIMIDE COPOLYMER AND METHOD FOR THE PRODUCTION THEREOF | |
| HUP0400231A3 (en) | Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer | |
| EP1560593A4 (en) | NEW COMPOSITION AND METHOD FOR THE TREATMENT OF IMMUNE DISEASES | |
| EP1442062A4 (en) | METHOD FOR TREATING CARCINOMA | |
| WO2003010291A3 (en) | Treatment of immune disorders and b cell disorders | |
| HUP0500617A3 (en) | Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders | |
| EP1456418A4 (en) | IDENTIFICATION OF NEW POLYMORPHIC LOCATIONS IN THE HUMAN MGLUR8 GEN AND USES THEREOF | |
| EP1472273A4 (en) | COMPOSITIONS AND METHODS FOR TREATING IMMUNE DISEASES | |
| HUP0401577A3 (en) | Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses | |
| EP1440080A4 (en) | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATION DISORDERS INVOLVING THE 20750 | |
| EP1404707A4 (en) | SYSTEMS AND METHODS FOR PROTEIN ANALYSIS | |
| AU2002339673A1 (en) | Agonists and antagonists of ryzn for the treatment of metabolic disorders | |
| EP1433849A4 (en) | NEW POLYPEPTIDE, HIS DNA, AND USE THEREOF | |
| WO2004096848A8 (en) | Novel composition and methods for the treatment of immune disorders | |
| HUP0102561A3 (en) | Identification and cloning the gene of symbiotic nitrogen fixation receptor | |
| PL354111A1 (en) | Combined therapy for treating the both depression and anxiety | |
| EP1463799A4 (en) | PROCESS FOR INDUCTION OF LEARNED AND CYTOKINE-PRODUCING REGULATORY CELLS | |
| EP1440165A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CELL PROLIFERATION DISORDERS USING 25943 | |
| AU2003255504A8 (en) | Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors | |
| AU2002339680A1 (en) | Agonists and antagonists of bromix for the treatment of metabolic disorders | |
| EP1439851A4 (en) | METHOD AND COMPOSITIONS FOR TREATMENT AND DIAGNOSIS OF CELL PROBLEMS BY USING 54394 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |